EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MSCs relieve SLE by modulation of Th17 cells through MMPs–CCL2–CCR2–IL‐17 pathway

Bo Jiang, Genhong Yao, Xiaojun Tang, Xi Yang, Xuebing Feng

Rheumatology & Autoimmunity · 2021

DOI: 10.1002/rai2.12002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology & Autoimmunity, 2021. Verfasst von Bo Jiang und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the modulation of mesenchymal stem cells (MSCs) on T helper 17 (Th17) cells in systemic lupus erythematosus (SLE) and underlying mechanism.

Methods

The concentration of matrix metalloproteinases (MMPs), CC chemokine ligand‐2 (CCL2), and interleukin‐17 (IL‐17) in the serum of SLE patients and mice were detected by enzyme‐linked immunosorbent assay. The expression of CCR2 and IL‐17 of T lymphocytes were determined by flow cytometry. The effects of MSCs on Th17 cells were analyzed in lupus mice and coculture system in vitro.

Results

The levels of MMPs, CCL2, IL‐17, CCR2, and percentages of Th17 cells were significantly increased in SLE patients. These molecules and numbers of Th17 cells were downregulated by umbilical cord‐derived MSCs (UC‐MSCs) which relieve SLE disease. CCL2 neutralizing antibody blocked the effects of MSCs on Th17 cells. MMPs reversed the function of CCL2.

Conclusion

The beneficial effects of MSCs on SLE patients rely on secreting MMPs, which reverse the activity of CCL2 to inhibit Th17 cells, suggesting the crucial MSCs–MMP–CCL2–CCR2–Th17–IL‐17 pathway in SLE.

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Jiang, B., Yao, G., Tang, X., Yang, X., & Feng, X. (2021). MSCs relieve SLE by modulation of Th17 cells through MMPs–CCL2–CCR2–IL‐17 pathway. Rheumatology & Autoimmunity. https://doi.org/10.1002/rai2.12002

Vancouver

Jiang B, Yao G, Tang X, Yang X, Feng X. MSCs relieve SLE by modulation of Th17 cells through MMPs–CCL2–CCR2–IL‐17 pathway. Rheumatology & Autoimmunity. 2021. doi:10.1002/rai2.12002

BibTeX
@article{Jiang2021,
  author = {Jiang, Bo and Yao, Genhong and Tang, Xiaojun and Yang, Xi and Feng, Xuebing},
  title = {MSCs relieve SLE by modulation of Th17 cells through MMPs–CCL2–CCR2–IL‐17 pathway},
  journal = {Rheumatology & Autoimmunity},
  year = {2021},
  doi = {10.1002/rai2.12002}
}
Kostenlos starten →